Drugs / rimicade
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05540743 | Jul 2022 → Dec 2023 | unspecified juvenile idiopathic arthritis | Kasr El Aini Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rimicade | “rimicade, adalimumab” NCT05540743 ↗ |